OptiBiotix Health (LON:OPTI) Stock Price Down 1.7% – Should You Sell?

Shares of OptiBiotix Health Plc (LON:OPTI) traded down 1.7% on Thursday. The stock traded as low as GBX 5.80 and last traded at GBX 5.80. 193,493 shares traded hands during mid-day trading, a decline of 43% from the average session volume of 338,455 shares. The stock had previously closed at GBX 5.90.

OptiBiotix Health Stock Performance

The company has a 50-day moving average of GBX 5.82 and a 200 day moving average of GBX 5.72. The firm has a market cap of £6.20 million, a P/E ratio of -1.43 and a beta of 1.82.

OptiBiotix Health (LON:OPTI) last issued its quarterly earnings data on Thursday, September 17th. The company reported GBX (1.52) earnings per share (EPS) for the quarter. OptiBiotix Health had a negative net margin of 332.69% and a negative return on equity of 77.85%.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.